Indefinite Delivery Contract SPE2DX23D9265
Award Date 3/6/23
Last Date to Order 12/31/25
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The Indefinite Delivery Contract was awarded as a single award by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc. The contract has a potential value of $4,999,999 and a period of performance through December 31, 2025. The SPE2DX contract provides pharmaceutical products and services to the Prime Vendor Pharmacy Branch located in Philadelphia, Pennsylvania. As a prime vendor contract, it establishes DMS Pharmaceutical Group Inc. as the primary supplier for...
- This single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DX program enables the procurement of a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The prime contractor, DMS Pharmaceutical Group Inc., is a woman-owned small business pharmaceutical wholesaler that provides branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables...
- The Indefinite Delivery Contract was awarded as a single award by the Defense Logistics Agency to DMS Pharmaceutical Group Inc. With a potential value of $499,999,999, the contract supports the Prime Vendor Pharmaceutical Branch in Philadelphia through December 31, 2025. The SPE2DB program aims to procure pharmaceutical products and services for the Defense Logistics Agency through a prime vendor arrangement. DMS Pharmaceutical Group Inc. will deliver pharmaceuticals and manage distribution to...
- The single award Indefinite Delivery Contract SPE2DB was issued on May 19, 2022 by the Defense Logistics Agency to provide pharmaceutical products and services. With a potential value of $499,999,999, the contract utilizes no set-asides and has a period of performance through December 31, 2025. DMS Pharmaceutical Group Inc. will serve as the prime vendor for the DLA's Philadelphia branch, supplying pharmaceuticals to support Defense Department operations. The original solicitation sought a...
- The federal contract IDV award SPE2DX15D9404 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and awarded to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA) under the SPE2DX program, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities...
- This single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DX program aims to provide the U.S. Department of Defense (DoD) with a comprehensive range of pharmaceutical products and medical supplies. The prime contractor, DMS Pharmaceutical Group Inc., is a woman-owned small business based in Park Ridge, Illinois, that specializes in federal government pharmaceutical procurement. The IDC, valued at $4,999,999, covers a diverse portfolio of branded...
- The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical needs of the Department of Defense (DoD) and other federal government agencies. The $4,999,999 IDC, awarded under the SPE2DB program, has an ultimate completion date of March 6, 2036 and enables the...
- The Defense Logistics Agency Troop Support Medical awarded a single award indefinite delivery/indefinite quantity contract to DMS Pharmaceutical Group Inc. to fulfill requirements for pharmaceutical products and medical supplies. The IDV has a potential value of $4,999,999 with performance through December 31, 2025. The agency issued numerous fixed price delivery orders against the IDV to DMS Pharmaceutical Group for various pharmaceutical products. The orders detailed in the solicitation...
- The contract ID SPE2DX16D9942 is an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued at $4,999,999.99, was awarded on April 18, 2016 and has an ultimate completion date of December 31, 2025. The contract enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including...
- The federal contract IDV award, SPE2DX15D9123, is a single-award Indefinite Delivery Contract (IDC) with a ceiling value of $4,999,999.00 held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract was awarded by the Defense Logistics Agency (DLA) under the SPE2DX program and has a period of performance through December 31, 2025. Under this IDC, DMS Pharmaceutical Group is the prime contractor responsible for providing a comprehensive range of...